11:09 AM
Jan 18, 2017
 |  BC Innovations  |  Distillery Therapeutics



Mouse studies suggest inhibiting NAT8L could help treat Canavan disease. In a mouse model of the disease, knockout of NAT8L decreased vacuolation of the cerebellum,...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >